Technical Analysis for CASI - CASI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 3.64 -4.21% -0.16
CASI closed down 4.21 percent on Friday, January 18, 2019, on 60 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CASI trend table...

Date Alert Name Type % Chg
Jan 18 180 Bearish Setup Bearish Swing Setup 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Oversold Stochastic Weakness 0.00%
Jan 17 Hammer Candlestick Bullish -4.21%
Jan 17 Stochastic Buy Signal Bullish -4.21%
Jan 17 Lower Bollinger Band Touch Weakness -4.21%
Jan 17 Oversold Stochastic Weakness -4.21%
Jan 16 20 DMA Resistance Bearish -3.45%
Jan 16 50 DMA Resistance Bearish -3.45%
Jan 16 180 Bearish Setup Bearish Swing Setup -3.45%

Older signals for CASI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. The company's lead drug candidate includes ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer, which has completed Phase I studies in patients with advanced solid tumors, multiple myeloma, and leukemia, as well as it is completing data for a multi-center Phase II study in patients with platinum resistant ovarian cancer. Its other product candidates in development include 2-methoxyestrdiol, an orally active compound for autoimmune diseases; and MKC-1, an orally-active cell cycle inhibitor that has completed Phase II clinical trials for cancer treatment. The company name was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Rockville, Maryland.
Is CASI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.89
52 Week Low 2.73
Average Volume 396,787
200-Day Moving Average 5.7216
50-Day Moving Average 3.9605
20-Day Moving Average 4.015
10-Day Moving Average 3.894
Average True Range 0.2837
ADX 11.31
+DI 17.9598
-DI 20.5384
Chandelier Exit (Long, 3 ATRs ) 3.7289
Chandelier Exit (Short, 3 ATRs ) 4.3611
Upper Bollinger Band 4.443
Lower Bollinger Band 3.587
Percent B (%b) 0.06
BandWidth 21.32005
MACD Line -0.0814
MACD Signal Line -0.031
MACD Histogram -0.0504
Fundamentals Value
Market Cap 219.12 Million
Num Shares 60.2 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -28.00
Price-to-Sales 0.00
Price-to-Book 7.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.96
Resistance 3 (R3) 3.98 3.91 3.90
Resistance 2 (R2) 3.91 3.83 3.89 3.88
Resistance 1 (R1) 3.77 3.78 3.74 3.75 3.87
Pivot Point 3.70 3.70 3.68 3.68 3.70
Support 1 (S1) 3.56 3.62 3.53 3.54 3.41
Support 2 (S2) 3.49 3.57 3.47 3.40
Support 3 (S3) 3.35 3.49 3.38
Support 4 (S4) 3.33